Exploring suicidal and self-injurious behaviors signal strength of biologics in treating psoriasis or psoriatic arthritis: A 10-year real-world pharmacovigilance analysis using the FDA Adverse Event Reporting System database - 04/11/24
This article has been published in an issue click here to access
Key words : biologics, FAERS, psoriasis, psoriasis arthritis, self-injury, suicide
Drs Cheng and Chen contributed equally to this paper. |
|
Funding sources: This work is supported by the Guangdong Medical Science and Technology Research Fund (A2024562) and National Natural Science Foundation of China (No. 82273537). |
|
Patient consent: Not applicable. |
|
IRB approval status: This article is a retrospective, observational, pharmacovigilance study done on a deidentified publicly available FAERS dataset, which did not require IRB approval. |
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?